BofA lowered the firm’s price target on Lyell Immunopharma (LYEL) to 60c from $1 and keeps an Underperform rating on the shares. The firm said on Friday that Lyell provided a business update ...

Investors might want to bet on Lyell Immunopharma (LYEL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Given the large stake in the stock by institutions, Lyell Immunopharma's stock price might be vulnerable to their trading decisions 50% of the business is held by the top 8 shareholders Using data ...

Lyell Immunopharma (NASDAQ:LYEL) has until July 22, 2025, to regain compliance with the minimum bid price rule. To do so, the company's stock must maintain a closing bid price of at least $1.00 ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Lyell Immunopharma (LYEL – Research Report) and Gilead Sciences (GILD – Research Report).